The overexpression of CDKN2B-AS1, which ranked 8, can inhibit the proliferation and invasion of liver cancer cells (Hua et al., 2015), thereby promoting the apoptosis of liver cancer cells and preventing the occurrence of hepatocellular carcinoma. Here, CDKN2B is linked to hepatocellular carcinoma.